112 related articles for article (PubMed ID: 12850144)
1. NFATc1 with AP-3 site binding specificity mediates gene expression of prostate-specific-membrane-antigen.
Lee SJ; Lee K; Yang X; Jung C; Gardner T; Kim HS; Jeng MH; Kao C
J Mol Biol; 2003 Jul; 330(4):749-60. PubMed ID: 12850144
[TBL] [Abstract][Full Text] [Related]
2. Sox7 negatively regulates prostate-specific membrane antigen (PSMA) expression through PSMA-enhancer.
Peng W; Guo L; Tang R; Liu X; Jin R; Dong JT; Xing CG; Zhou W
Prostate; 2019 Mar; 79(4):370-378. PubMed ID: 30488457
[TBL] [Abstract][Full Text] [Related]
3. A tissue-specific enhancer of the prostate-specific membrane antigen gene, FOLH1.
Watt F; Martorana A; Brookes DE; Ho T; Kingsley E; O'Keefe DS; Russell PJ; Heston WD; Molloy PL
Genomics; 2001 May; 73(3):243-54. PubMed ID: 11350116
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of prostate specific membrane antigen/folate hydrolase transcription by an enhancer.
Noss KR; Wolfe SA; Grimes SR
Gene; 2002 Feb; 285(1-2):247-56. PubMed ID: 12039052
[TBL] [Abstract][Full Text] [Related]
5. AP-2 gamma and the homeodomain protein distal-less 3 are required for placental-specific expression of the murine 3 beta-hydroxysteroid dehydrogenase VI gene, Hsd3b6.
Peng L; Payne AH
J Biol Chem; 2002 Mar; 277(10):7945-54. PubMed ID: 11773066
[TBL] [Abstract][Full Text] [Related]
6. Transcription enhancer factor 1 binds multiple muscle MEF2 and A/T-rich elements during fast-to-slow skeletal muscle fiber type transitions.
Karasseva N; Tsika G; Ji J; Zhang A; Mao X; Tsika R
Mol Cell Biol; 2003 Aug; 23(15):5143-64. PubMed ID: 12861002
[TBL] [Abstract][Full Text] [Related]
7. Prostate-specific suicide gene therapy using the prostate-specific membrane antigen promoter and enhancer.
O'Keefe DS; Uchida A; Bacich DJ; Watt FB; Martorana A; Molloy PL; Heston WD
Prostate; 2000 Oct; 45(2):149-57. PubMed ID: 11027414
[TBL] [Abstract][Full Text] [Related]
8. Nuclear factor of activated T cells and serum response factor cooperatively regulate the activity of an alpha-actin intronic enhancer.
Gonzalez Bosc LV; Layne JJ; Nelson MT; Hill-Eubanks DC
J Biol Chem; 2005 Jul; 280(28):26113-20. PubMed ID: 15857835
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Nfatc1 regulation identifies an enhancer required for gene expression that is specific to pro-valve endocardial cells in the developing heart.
Zhou B; Wu B; Tompkins KL; Boyer KL; Grindley JC; Baldwin HS
Development; 2005 Mar; 132(5):1137-46. PubMed ID: 15689382
[TBL] [Abstract][Full Text] [Related]
10. Molecular regulation of the human IL-3 gene: inducible T cell-restricted expression requires intact AP-1 and Elf-1 nuclear protein binding sites.
Gottschalk LR; Giannola DM; Emerson SG
J Exp Med; 1993 Nov; 178(5):1681-92. PubMed ID: 8228815
[TBL] [Abstract][Full Text] [Related]
11. Multiple cis-elements mediate the transcriptional activation of human fra-1 by 12-O-tetradecanoylphorbol-13-acetate in bronchial epithelial cells.
Adiseshaiah P; Papaiahgari SR; Vuong H; Kalvakolanu DV; Reddy SP
J Biol Chem; 2003 Nov; 278(48):47423-33. PubMed ID: 13679379
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional regulation of the p67phox gene: role of AP-1 in concert with myeloid-specific transcription factors.
Li SL; Valente AJ; Wang L; Gamez MJ; Clark RA
J Biol Chem; 2001 Oct; 276(42):39368-78. PubMed ID: 11483614
[TBL] [Abstract][Full Text] [Related]
13. ZNF143 mediates basal and tissue-specific expression of human transaldolase.
Grossman CE; Qian Y; Banki K; Perl A
J Biol Chem; 2004 Mar; 279(13):12190-205. PubMed ID: 14702349
[TBL] [Abstract][Full Text] [Related]
14. Identification of an enhancer of the human activating protein-2alpha gene that contains a critical Ets1 binding site.
Cheng YH; Handwerger S
J Clin Endocrinol Metab; 2003 Jul; 88(7):3305-11. PubMed ID: 12843180
[TBL] [Abstract][Full Text] [Related]
15. Granulocyte-macrophage colony-stimulating factor enhancer activation requires cooperation between NFAT and AP-1 elements and is associated with extensive nucleosome reorganization.
Johnson BV; Bert AG; Ryan GR; Condina A; Cockerill PN
Mol Cell Biol; 2004 Sep; 24(18):7914-30. PubMed ID: 15340054
[TBL] [Abstract][Full Text] [Related]
16. A ternary complex of transcription factors, Nishéd and NFATc4, and co-activator p300 bound to an intronic sequence, intronic regulatory element, is pivotal for the up-regulation of myosin light chain-2v gene in cardiac hypertrophy.
Mathew S; Mascareno E; Siddiqui MA
J Biol Chem; 2004 Sep; 279(39):41018-27. PubMed ID: 15272022
[TBL] [Abstract][Full Text] [Related]
17. Targeting prostate cancer with conditionally replicative adenovirus using PSMA enhancer.
Lee SJ; Zhang Y; Lee SD; Jung C; Li X; Kim HS; Bae KH; Jeng MH; Kao C; Gardner T
Mol Ther; 2004 Dec; 10(6):1051-8. PubMed ID: 15564137
[TBL] [Abstract][Full Text] [Related]
18. Vezf1/DB1 is an endothelial cell-specific transcription factor that regulates expression of the endothelin-1 promoter.
Aitsebaomo J; Kingsley-Kallesen ML; Wu Y; Quertermous T; Patterson C
J Biol Chem; 2001 Oct; 276(42):39197-205. PubMed ID: 11504723
[TBL] [Abstract][Full Text] [Related]
19. Site-directed mutagenesis of hepatocyte nuclear factor (HNF) binding sites in the mouse transthyretin (TTR) promoter reveal synergistic interactions with its enhancer region.
Costa RH; Grayson DR
Nucleic Acids Res; 1991 Aug; 19(15):4139-45. PubMed ID: 1870969
[TBL] [Abstract][Full Text] [Related]
20. Methylation state of the prostate specific membrane antigen (PSMA) CpG island in prostate cancer cell lines.
Noss KR; Singal R; Grimes SR
Anticancer Res; 2002; 22(3):1505-11. PubMed ID: 12168830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
